Patent details

EP2729459 Title: SUBSTITUTED AZAHETEROCYCLES FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP2729459
PCT Application Number:
EP2012002469
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127293520
PCT Publication Number:
WO2013004332
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED AZAHETEROCYCLES FOR THE TREATMENT OF CANCER
French Title of Invention:
AZAHETEROCYCLES SUBSTITUES POUR LE TRAITEMENT DU CANCER
German Title of Invention:
SUBSTITUIERTE AZAHETEROCYCLEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
11/06/2012
Grant date:
22/08/2018
EP Publication Date:
14/05/2014
PCT Publication Date:
10/01/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/08/2018
EP B1 Publication Date:
22/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/06/2019
Expiration date:
11/06/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2018
 
 

Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:
JOSEPHSON, Kristopher
Address:
United States (US)

2

Name:
BRUGGER, Nadia
Address:
United States (US)

3

Name:
HEINRICH, Timo
Address:
Germany (DE)

Priority

Priority Number:
201161505376 P
Priority Date:
07/07/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/506; A61P 35/00; C07D 401/04; C07D 401/12; C07D 401/14; C07D 405/14; C07D 413/14; C07D 417/14; C07D 471/04; C07D 473/34;

Publication

European Patent Bulletin

Issue number:
201834
Publication date:
22/08/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages